Preliminary Report on the Effect of a Lower Dose of Gonadotropin-Releasing Hormone Antagonist (Cetrorelix) on Ovarian Hyperstimulation in Lower-Weight Asian Women
Objective: To determine the minimal effective daily dose of gonadotropin-releasing hormone (GnRH) antagonist in lower-weight Asian women undergoing controlled ovarian hyperstimulation (COH). Materials and Methods: A prospective randomized controlled trial of GnRH antagonist was performed. A total of...
Saved in:
Main Authors: | Yung-Ling Chang (Author), Yao-Yuan Hsieh (Author), Horng-Der Tsai (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2006-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparisons of Different Dosages of Gonadotropin-Releasing Hormone (GnRH) Antagonist, Short-acting Form and Single, Half-dose, Long-acting Form of GnRH Agonist During Controlled Ovarian Hyperstimulation and in vitro Fertilization
by: Yao-Yuan Hsieh, et al.
Published: (2008) -
A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation
by: I-Ting Liang, et al.
Published: (2015) -
Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review
by: Caroline Ingold, et al.
Published: (2023) -
Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
by: Kristof Chwalisz, M.D., Ph.D
Published: (2023) -
Diminished ovarian reserve predisposes to premature luteinizing hormone surges in gonadotropin-releasing hormone antagonist cycles in In vitro fertilization
by: Puneet Kaur Kochhar, et al.
Published: (2020)